|
🐜
|
Prebiotic effects: metabolic and health benefits
21 auth.
M. Roberfroid,
G. Gibson,
L. Hoyles,
A. McCartney,
R. Rastall,
I. Rowland,
D. Wolvers,
B. Watzl,
H. Szajewska,
B. Stahl,
...
F. Guarner,
F. Respondek,
K. Whelan,
V. Coxam,
M. Davicco,
L. Léotoing,
Y. Wittrant,
N. Delzenne,
Patrice D Cani,
A. Neyrinck,
Agnès Méheust
|
10 |
2010 |
10
🐜
|
|
🐬
|
Oxidative stress in bone remodelling and disease.
F. Wauquier,
L. Léotoing,
V. Coxam,
J. Guicheux,
Y. Wittrant
|
8 |
2009 |
8
🐬
|
|
🐜
|
Androgen Receptor Mediates Non-genomic Activation of Phosphatidylinositol 3-OH Kinase in Androgen-sensitive Epithelial Cells*
7 auth.
Silvère Baron,
M. Manin,
C. Beaudoin,
L. Léotoing,
Y. Communal,
G. Veyssière,
...
L. Morel
|
7 |
2004 |
7
🐜
|
|
🐜
|
The Free Fatty Acid Receptor G Protein-coupled Receptor 40 (GPR40) Protects from Bone Loss through Inhibition of Osteoclast Differentiation*
13 auth.
F. Wauquier,
Claire Philippe,
L. Léotoing,
S. Mercier,
M. Davicco,
P. Lebecque,
J. Guicheux,
P. Pilet,
E. Miot-Noirault,
V. Poitout,
...
T. Alquier,
V. Coxam,
Y. Wittrant
|
6 |
2013 |
6
🐜
|
|
🐜
|
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia.
16 auth.
N. Chapuis,
Sophie Park,
L. Léotoing,
J. Tamburini,
F. Verdier,
V. Bardet,
A. Green,
L. Willems,
F. Agou,
N. Ifrah,
...
F. Dreyfus,
G. Bismuth,
V. Baud,
C. Lacombe,
P. Mayeux,
D. Bouscary
|
6 |
2010 |
6
🐜
|
|
🦁
|
The Polyphenol Fisetin Protects Bone by Repressing NF-κB and MKP-1-Dependent Signaling Pathways in Osteoclasts
L. Léotoing,
F. Wauquier,
J. Guicheux,
E. Miot-Noirault,
Y. Wittrant,
V. Coxam
|
6 |
2013 |
6
🦁
|
|
🦁
|
Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell
11 auth.
L. Léotoing,
L. Meunier,
M. Manin,
C. Mauduit,
M. Decaussin,
G. Verrijdt,
...
F. Claessens,
M. Benahmed,
G. Veyssière,
L. Morel,
C. Beaudoin
|
6 |
2008 |
6
🦁
|
|
🐜
|
Pomegranate Peel Extract Prevents Bone Loss in a Preclinical Model of Osteoporosis and Stimulates Osteoblastic Differentiation in Vitro
9 auth.
Mélanie Spilmont,
L. Léotoing,
M. Davicco,
P. Lebecque,
E. Miot-Noirault,
P. Pilet,
...
L. Rios,
Y. Wittrant,
V. Coxam
|
5 |
2015 |
5
🐜
|
|
🐜
|
Pomegranate and its derivatives can improve bone health through decreased inflammation and oxidative stress in an animal model of postmenopausal osteoporosis
10 auth.
Mélanie Spilmont,
L. Léotoing,
M. Davicco,
P. Lebecque,
S. Mercier,
E. Miot-Noirault,
...
P. Pilet,
L. Rios,
Y. Wittrant,
V. Coxam
|
5 |
2014 |
5
🐜
|
|
🦁
|
Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.
9 auth.
L. Léotoing,
M. Manin,
D. Monté,
Silvère Baron,
Y. Communal,
Corinne Lours,
...
G. Veyssière,
L. Morel,
C. Beaudoin
|
5 |
2007 |
5
🦁
|
|
🐜
|
Pomegranate seed oil prevents bone loss in a mice model of osteoporosis, through osteoblastic stimulation, osteoclastic inhibition and decreased inflammatory status.
10 auth.
Mélanie Spilmont,
L. Léotoing,
M. Davicco,
P. Lebecque,
S. Mercier,
E. Miot-Noirault,
...
P. Pilet,
L. Rios,
Y. Wittrant,
V. Coxam
|
5 |
2013 |
5
🐜
|
